NuVasive Current Ratio 2006-2019 | NUVA

NuVasive current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
NuVasive Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.66B $0.19B 3.60
2019-03-31 $0.61B $0.16B 3.75
2018-12-31 $0.62B $0.18B 3.45
2018-09-30 $0.58B $0.17B 3.45
2018-06-30 $0.57B $0.20B 2.80
2018-03-31 $0.56B $0.23B 2.41
2017-12-31 $0.56B $0.16B 3.47
2017-09-30 $0.53B $0.19B 2.85
2017-06-30 $0.59B $0.25B 2.40
2017-03-31 $0.56B $0.23B 2.40
2016-12-31 $0.58B $0.24B 2.37
2016-09-30 $0.62B $0.28B 2.20
2016-06-30 $0.71B $0.30B 2.36
2016-03-31 $0.69B $0.13B 5.41
2015-12-31 $0.70B $0.10B 7.06
2015-09-30 $0.70B $0.10B 7.03
2015-06-30 $0.68B $0.13B 5.17
2015-03-31 $0.63B $0.11B 5.55
2014-12-31 $0.66B $0.21B 3.07
2014-09-30 $0.63B $0.17B 3.72
2014-06-30 $0.59B $0.16B 3.69
2014-03-31 $0.61B $0.16B 3.87
2013-12-31 $0.54B $0.12B 4.58
2013-09-30 $0.49B $0.11B 4.52
2013-06-30 $0.45B $0.10B 4.46
2013-03-31 $0.46B $0.10B 4.58
2012-12-31 $0.51B $0.16B 3.13
2012-09-30 $0.52B $0.19B 2.68
2012-06-30 $0.52B $0.19B 2.75
2012-03-31 $0.63B $0.29B 2.19
2011-12-31 $0.59B $0.21B 2.85
2011-09-30 $0.58B $0.21B 2.85
2011-06-30 $0.73B $0.10B 7.15
2011-03-31 $0.39B $0.10B 3.82
2010-12-31 $0.37B $0.11B 3.41
2010-09-30 $0.35B $0.06B 5.91
2010-06-30 $0.34B $0.05B 6.39
2010-03-31 $0.34B $0.05B 6.32
2009-12-31 $0.32B $0.06B 5.79
2009-09-30 $0.33B $0.06B 5.40
2009-06-30 $0.30B $0.05B 5.74
2009-03-31 $0.32B $0.07B 4.37
2008-12-31 $0.30B $0.05B 6.64
2008-09-30 $0.28B $0.04B 7.85
2008-06-30 $0.30B $0.03B 9.02
2008-03-31 $0.34B $0.03B 9.97
2007-12-31 $0.15B $0.03B 5.22
2007-09-30 $0.14B $0.02B 6.12
2007-06-30 $0.14B $0.02B 6.96
2007-03-31 $0.14B $0.02B 7.39
2006-12-31 $0.16B $0.02B 8.37
2006-09-30 $0.15B $0.02B 8.48
2006-06-30 $0.18B $0.03B 7.01
2006-03-31 $0.18B $0.01B 15.05
2005-12-31 $0.05B $0.01B 3.81
2005-09-30 $0.05B $0.01B 4.19
2005-06-30 $0.06B $0.01B 5.10
2005-03-31 $0.07B $0.01B 6.18
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.380B $1.102B
NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 28.00
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Boston Scientific (BSX) United States $58.240B 28.25
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
ResMed (RMD) United States $18.992B 36.22
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Omeros (OMER) United States $0.915B 0.00
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Meridian Bioscience (VIVO) United States $0.422B 13.16
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
United-Guardian (UG) United States $0.088B 20.72
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00